These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6156836)
21. Comparison of ultrasonic and indium-111-bleomycin scanning of gynecologic tumors. Alberts DS; Woolfenden JM; Haber K; Giles HR; Galindo J Gynecol Oncol; 1978 Apr; 6(2):145-51. PubMed ID: 77243 [No Abstract] [Full Text] [Related]
22. [Scintigraphy with 111In-bleomycin in the diagnosis of recurrences of rectal cancer]. Lenskaia OP; Ozhiganov EL; Bogdasarov IuB Med Radiol (Mosk); 1985 Nov; 30(11):7-11. PubMed ID: 2415800 [TBL] [Abstract][Full Text] [Related]
23. [Positive tumor scintigraphy. II. Clinical results with 111In-bleomycin]. Weiss ML; Deckart H Radiobiol Radiother (Berl); 1978 Jun; 19(3):378-86. PubMed ID: 82977 [No Abstract] [Full Text] [Related]
24. Bleomycin labelled with 99mTc for differentiation of breast tumors. Warczyglowa D; Szostak S; Marzecki Z; Tustanowski S Eur J Nucl Med; 1981 Feb; 6(2):59-61. PubMed ID: 6162640 [TBL] [Abstract][Full Text] [Related]
25. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women. Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of palpable breast masses with 201Tl scintigraphy. Rebollo AC; Torres-Avisbal M; Espinosa JE; Diaz C; Vallejo JA; Pacheco C; Pera C; Mateo A Br J Radiol; 1995 Oct; 68(814):1052-7. PubMed ID: 7496703 [TBL] [Abstract][Full Text] [Related]
27. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings]. Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292 [TBL] [Abstract][Full Text] [Related]
28. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043 [TBL] [Abstract][Full Text] [Related]
29. [Scintigraphy with 67Ga-citrate and 111In-bleomycin in cancer of the rectum]. Lenskaia OP; Ozhiganov EL; Bogdasarov IuB Med Radiol (Mosk); 1987 Dec; 32(12):38-43. PubMed ID: 2446100 [TBL] [Abstract][Full Text] [Related]
31. The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography. Cimitan M; Volpe R; Candiani E; Gusso G; Ruffo R; Borsatti E; Massarut S; Rossi C; Morassut S; Carbone A Eur J Nucl Med; 1995 Oct; 22(10):1110-7. PubMed ID: 8542893 [TBL] [Abstract][Full Text] [Related]
32. The value of ultrasound mammography in palpable breast masses. van Oord JC; van der Vliet AM; Thyn CJ; Mak B; Hoogeboom GJ Rofo; 1991 Jul; 155(1):63-6. PubMed ID: 1854938 [TBL] [Abstract][Full Text] [Related]
35. 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study. Li S; Kurtaran A; Li M; Traub-Weidinger T; Kienast O; Schima W; Angelberger P; Virgolini I; Raderer M; Dudczak R Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1087-95. PubMed ID: 12768334 [TBL] [Abstract][Full Text] [Related]
36. A comparative study of breast-specific gamma imaging with the conventional imaging modality in breast cancer patients with dense breasts. Kim BS; Moon BI; Cha ES Ann Nucl Med; 2012 Dec; 26(10):823-9. PubMed ID: 22922890 [TBL] [Abstract][Full Text] [Related]
37. Static and dynamic imaging with indium-III labelled Bleomycin in the localization of squamous cell neoplasia. Burton IE; Todd JH; Turner RL Br J Radiol; 1977 Jul; 50(595):508-12. PubMed ID: 68793 [TBL] [Abstract][Full Text] [Related]
38. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions. Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205 [TBL] [Abstract][Full Text] [Related]
39. The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast. Williams MR; Perkins AC; Campbell FC; Pimm MV; Hardy JG; Wastie ML; Blamey RW; Baldwin RW Clin Oncol; 1984 Dec; 10(4):375-81. PubMed ID: 6391773 [TBL] [Abstract][Full Text] [Related]